385 results on '"Papi, Claudio"'
Search Results
52. Acute kidney injury: an unexpected Isoniazid-related adverse event in a patient with Crohn's disease receiving prophylactic treatment for latent tuberculosis
53. Infliximab, azathioprine or combination therapy in the treatment of active Crohnʼs disease
54. Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
55. Long-Term Outcome of Crohnʼs Disease Following Corticosteroid-Induced Remission
56. Timing of Cholecystectomy for Acute Calculous Cholecystitis: A Meta-Analysis
57. Supplemental material for Early-onset versus late-onset Crohn's disease: An Italian cohort study
58. Early‐onset versus late‐onset Crohn’s disease: An Italian cohort study
59. Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
60. Separation of Low- Versus High-grade Crohn’s Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis
61. Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
62. Unmet needs of Italian physicians managing patients with inflammatory bowel disease
63. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study.
64. Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study
65. How thiopurines are used for the treatment of inflammatory bowel diseases: An Italian survey
66. A safety evaluation of budesonide MMX for the treatment of ulcerative colitis
67. The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study
68. Small Bowel Carcinomas in Coeliac or Crohn’s Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian Consortium
69. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
70. Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence
71. The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology
72. Colonic small cell neuroendocrine carcinoma in a patient with long-standing ulcerative colitis treated with azathioprine
73. Methotrexate in Crohn’s disease: a new face for an old drug?
74. Gastrointestinal bleeding and severe anaemia: An uncommon presentation of small bowel carcinoma complicating ileal Crohn's disease
75. 685 Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study
76. Su1266 Characterization of Incident Cases of Cancer in Inflammatory Bowel Disease: A Prospective Multicenter Nested Case-Control IG-IBD Study
77. Su1073 The SOLE Survey: Disease Related Concerns of a Large Cohort of Italian Patients With Active Crohn's Disease
78. Sa1788 Modifying the Clinical History of Recurrent Diverticulitis: A Pragmatic Trial With Mesalazine (M) or Rifaximin (R)
79. Newly diagnosed neoplasia in a cohort of Crohn’s Disease patients treated with Infliximab: a 3 years longer follow up from a multicenter matched-pair study
80. Author's Reply: ''Use of biologics for the management of Crohn's disease''.
81. Methotrexate-induced pneumonitis in a patient with Crohn's disease
82. Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease
83. Su1339 Ulcerative Colitis (UC) Diagnosed Over Age 65 Years -An IG-IBD Study
84. Su1366 Characterization of Incident Cases of Cancer in Inflammatory Bowel Disease: A Prospective Multicenter Matched-Pair IG-IBD Study
85. Sa1232 Infliximab Three-Dose Induction Regimen in Severe Corticosteroid-Refractory Ulcerative Colitis: Early and Late Outcome and Predictors of Colectomy
86. Tu1144 Could Infliximab Avoid Colectomy in Patients With Severe Ulcerative Colitis? A Multicentre Italian Experience
87. Mo1264 Clinical Characteristics of Inflammatory Bowel Disease May Influence the Cancer Risk When Using Immunomodulators: Incident Cases of Cancer in a Multicenter Case-Control Study
88. The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology.
89. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
90. Randomized Controlled Trials in Prevention of PostSurgical Recurrence in Crohn's Disease
91. Sa1270 Early Post-Operative Endoscopic Recurrence in Crohn's Disease Patients: Data From a Large Prospective Italian Multicenter Cohort
92. Su1917 Interobserver Agreement in IBD Endoscopic Scoring: Preliminary Results of an Ongoing IG-IBD Study
93. Oral Beclomethasone Dipropionate: A Critical Review of its Use in the Management of Ulcerative Colitis and Crohn’s Disease
94. Sa1887 Adalimumab in Active Ulcerative Colitis: A “Real-Life” Observational Study
95. Do not disturb the sleeping worm
96. Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis
97. Cancer in Crohnʼs Disease patients treated with infliximab: A long-term multicenter matched pair study
98. S1214 Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort
99. M1257 Rifaximin® Reduces Symptoms and Complications in Patients With Symptomatic Diverticular Disease (SDD): A Meta-Analysis
100. W1271 Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.